MatthiasJohannesSzabolcsMD

Pathology • New York, NY

Anatomic Pathology, Clinical Pathology

Professor, Pathology & Cell Biology, Columbia University College of Phys & Surg

Join to view full profile

Dr. Szabolcs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Szabolcs' full profile

Already have an account?

Office
200 Cabrini Blvd APT 115
New York, NY 10033
Phone+1 212-305-4637

Fax+1 212-305-1295

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1990 - 1994
University of Vienna Faculty of MedicineClass of 1989

Certifications & Licensure

NY State Medical License 1997 - 2025
PA State Medical License 1993 - 2016
MN State Medical License 1998 - 2000
American Board of Pathology Anatomic Pathology

Publications & Presentations

PubMed

10 citations
SATB2 in Neoplasms of Lung, Pancreatobiliary, and Gastrointestinal Origins.
Simona De Michele, Helen Remotti, Armando Del Portillo, Stephen M. Lagana, Matthias Szabolcs
American Journal of Clinical Pathology. 2021-01-04
148 citations
The hormonal action of IGF1 in postnatal mouse growth
Elias E. Stratikopoulos, Matthias Szabolcs, Ioannis Dragatsis, Apostolos Klinakis, Argiris Efstratiadis
Proceedings of the National Academy of Sciences of the United States of America. 2008-12-09
448 citations
Role for Akt3/Protein Kinase Bγ in Attainment of Normal Brain Size
Rachael M. Easton, Han Cho, Kristin Roovers, Diana W. Shineman, Moshe Mizrahi
Molecular and Cellular Biology. 2005-03-01

Journal Articles

Article the BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection
Matthias Szabolcs, MD, ScienceDirect
Mouse ER+/PIK3CAH1047R Breast Cancers Caused by Exogenous Estrogen Are Heterogeneously Dependent on Estrogen and Undergo BIM-Dependent Apoptosis with BH3 and PI3K Agents
Matthias Szabolcs, Ramon Parsons, Hank Schmidt, Nature

Press Mentions

Boston Cell Standards Wins FDA $510K Clearance for Anatomic Pathology ControlsOctober 12th, 2022
FLT1 Activation in Cancer Cells Promotes PARP-Inhibitor Resistance in Breast CancerJuly 8th, 2024